INTERCEPT PHARMACEUTICALS, INC.·4

Mar 16, 4:07 PM ET

Berrey M Michelle 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Mar 16, 2023

Insider Transaction Report

Form 4
Period: 2023-03-14
Berrey M Michelle
President, R&D and CMO
Transactions
  • Tax Payment

    Common Stock

    2023-03-14$15.79/sh1,246$19,67482,631 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm239700-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT